Advertisement
Screener

Avantor, Inc. (AVTR) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.9 / 5 stars · 29/75 Roast Me

Avantor, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Avantor, Inc. (AVTR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 18.30 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-04-29

  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.30M shares, a 59.13% increase year-over-year.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 15.50M shares, a 229.79% increase year-over-year.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 16.70M shares, a 173.77% increase year-over-year.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 11.50M shares.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 14.50M shares, a 145.76% increase from fiscal 2024.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.90M shares, a 54.26% decline from fiscal 2023.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.90M shares.
  • Avantor, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 90.10M shares, a 327.01% increase from fiscal 2018.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month
2026-03-3118.30M shares
10-Q · filed 2026-04-29
2025-12-3114.50M shares
10-K · filed 2026-02-11
2025-09-3015.50M shares
10-Q · filed 2025-10-29
14.50M shares
10-Q · filed 2025-10-29
2025-06-3016.70M shares
10-Q · filed 2025-08-01
14.70M shares
10-Q · filed 2025-08-01
2025-03-3111.50M shares
10-Q · filed 2026-04-29
2024-12-315.90M shares
10-K · filed 2026-02-11
2024-09-304.70M shares
10-Q · filed 2025-10-29
6.10M shares
10-Q · filed 2025-10-29
2024-06-306.10M shares
10-Q · filed 2025-08-01
6.50M shares
10-Q · filed 2025-08-01
2023-12-3112.90M shares
10-K · filed 2026-02-11
2019-12-3190.10M shares
10-K · filed 2022-02-11
2019-09-30100.10M shares
10-Q · filed 2019-11-05
2019-06-3092.50M shares
10-Q · filed 2020-07-29
92.50M shares
10-Q · filed 2020-07-29
2018-12-3121.10M shares
10-K · filed 2021-02-16
2018-09-3019.30M shares
10-Q · filed 2019-11-05
19.30M shares
10-Q · filed 2019-11-05
2018-06-3018.60M shares
10-Q · filed 2019-08-06
18.60M shares
10-Q · filed 2019-08-06
2017-12-3119.60M shares
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34